Efficacy and Safety of Dulaglutide Monotherapy Versus Metformin in Type 2 Diabetes in a Randomized Controlled Trial (AWARD-3) von UMPIERREZ, Guillermo, POVEDANO, Santiago Tofé, MANGHI, Federico Pérez, SHURZINSKE, Linda, PECHTNER, Valeria

Volltext

Effect of Insulin Glargine Up-titration vs Insulin Degludec/Liraglutide on Glycated Hemoglobin Levels in Patients With Uncontrolled Type 2 Diabetes: The DUAL V Randomized Clinical... von Lingvay, Ildiko, Manghi, Federico Pérez, García-Hernández, Pedro, Norwood, Paul, Lehmann, Lucine, Tarp-Johansen, Mads Jeppe, Buse, John B

Volltext

Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes von Frías, Juan P, Davies, Melanie J, Rosenstock, Julio, Pérez Manghi, Federico C, Fernández Landó, Laura, Bergman, Brandon K, Liu, Bing, Cui, Xuewei, Brown, Katelyn

Volltext

Ultra‐rapid lispro improved postprandial glucose control compared to insulin lispro in predominantly Chinese patients with type 1 diabetes: A prospective, randomized, double‐blind... von Ma, Jianhua, Yan, Xiang, Feng, Qiong, Liu, Wei, Pérez Manghi, Federico, García‐Hernández, Pedro, Wang, Guixia, Xu, Jianwei, Yuan, Yuan, Zhou, Zhiguang

Volltext

Hypoglycaemia in patients with type 1 and type 2 diabetes mellitus on insulin therapy. Results of the global HAT study in Argentina von Costa Gil, José E, Linari, María A, Pugnaloni, Natalia, Zambon, Fabio G, Pérez Manghi, Federico, Rezzónico, Mariana

Volltext

Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome von Pfeffer, Marc A, Claggett, Brian, Diaz, Rafael, Dickstein, Kenneth, Gerstein, Hertzel C, Køber, Lars V, Lawson, Francesca C, Ping, Lin, Wei, Xiaodan, Lewis, Eldrin F, Maggioni, Aldo P, McMurray, John J.V, Probstfield, Jeffrey L, Riddle, Matthew C, Solomon, Scott D, Tardif, Jean-Claude

Volltext

Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium-Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis von Rossing, Peter, Anker, Stefan D, Filippatos, Gerasimos, Pitt, Bertram, Ruilope, Luis M, Birkenfeld, Andreas L, McGill, Janet B, Rosas, Sylvia E, Joseph, Amer, Gebel, Martin, Roberts, Luke, Scheerer, Markus F, Bakris, George L, Agarwal, Rajiv

Volltext

84-LB: Efficacy and Safety of Tirzepatide vs. Semaglutide Once-Weekly as Add-On Therapy to Metformin in People with Type 2 Diabetes (SURPASS-2) von FRIAS, JUAN PABLO, DAVIES, MELANIE J., ROSENSTOCK, JULIO, PEREZ MANGHI, FEDERICO C., LANDO, LAURA FERNANDEZ, BERGMAN, BRANDON, LIU, BING, CUI, XUEWEI, BROWN, KATELYN

Volltext

Design and Baseline Characteristics of the Finerenone in Reducing Cardiovascular Mortality and Morbidity in Diabetic Kidney Disease Trial von Ruilope, Luis M., Agarwal, Rajiv, Anker, Stefan D., Bakris, George L., Filippatos, Gerasimos, Nowack, Christina, Kolkhof, Peter, Joseph, Amer, Mentenich, Nicole, Pitt, Bertram

Volltext

Design and Baseline Characteristics of the Finerenone in Reducing Kidney Failure and Disease Progression in Diabetic Kidney Disease Trial von Bakris, George L., Agarwal, Rajiv, Anker, Stefan D., Pitt, Bertram, Ruilope, Luis M., Nowack, Christina, Kolkhof, Peter, Ferreira, Anna C., Schloemer, Patrick, Filippatos, Gerasimos

Volltext

Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes According to Baseline HbA1c and Insulin Use: An Analysis From the FIDELIO-DKD Study von Rossing, Peter, Burgess, Ellen, Agarwal, Rajiv, Anker, Stefan D, Filippatos, Gerasimos, Pitt, Bertram, Ruilope, Luis M, Gillard, Pieter, MacIsaac, Richard J, Wainstein, Julio, Joseph, Amer, Brinker, Meike, Roessig, Lothar, Scott, Charlie, Bakris, George L

Volltext

Rationale, design, and baseline characteristics in Evaluation of LIXisenatide in Acute Coronary Syndrome, a long-term cardiovascular end point trial of lixisenatide versus placebo von Bentley-Lewis, Rhonda, MD, Aguilar, David, MD, Riddle, Matthew C., MD, Claggett, Brian, PhD, Diaz, Rafael, MD, Dickstein, Kenneth, MD, PhD, Gerstein, Hertzel C., MD, Johnston, Peter, MD, Køber, Lars V., MD, Lawson, Francesca, MD, Lewis, Eldrin F., MD, Maggioni, Aldo P., MD, McMurray, John J.V., MD, Ping, Lin, MD, Probstfield, Jeffrey L., MD, Solomon, Scott D., MD, Tardif, Jean-Claude, MD, Wu, Yujun, PhD, Pfeffer, Marc A., MD, PhD

Volltext

Erratum. Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes According to Baseline HbA1c and Insulin Use: An Analysis From the FIDELIO-DKD Study. Diabetes Care 2... von Rossing, Peter, Burgess, Ellen, Agarwal, Rajiv, Anker, Stefan D, Filippatos, Gerasimos, Pitt, Bertram, Ruilope, Luis M, Gillard, Pieter, MacIsaac, Richard J, Wainstein, Julio, Joseph, Amer, Brinker, Meike, Roessig, Lothar, Scott, Charlie, Bakris, George L

Volltext

Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): a randomised, open-label, parallel-group, multicentre, phase 3 trial von Del Prato, Stefano, Pavo, Imre, Weerakkody, Govinda J, Yang, Zhengyu, Aizenberg, Diego, Wynne, Alan G, Wiese, Russell J, Arora, Samir, Calderon, Rafael B, Butuk, David J, Chaychi, Leila, Curtis, Brian M, Chochinov, Ronald, Chow, Christopher, Cone, Clancy L, Dungan, Kathleen, Gaudiani, Linda, Herandez-Vazquez, Luis, Hsia, Stanley H, Kutner, Mark E, Loy, Juan, Miranda, Francisco G, Oliver, Michael J, Parke, Michael T, Philis-Tsimikas, Athena, Rosenstock, Julio, Sorial, Ehab, Stonesifer, Larry D, Stringam, Stanley, Van, Joanna T, Vazquez-Tanus, Jose B, Reyes, Ramon, Karimjee, Najmuddin, Martin, Earl E, Fraser, Neil J, Bhargava, Anuj, Wynne, Alan G, Billings, Liana, Walsh, Patrick, Shubrook, Jay, Knouse, Albert B, Mayfield, Ronald K, Bitar, Fahed G, de la Cuesta, Carmen, Morales Portillo, Cristobal J, Quesada Charneco, Miguel, Tofe Povedano, Santiago, Vazquez, Luis, Soto Gonzalez, Alfonso, Ciomos, Daniela, Neacsu, Valentina, Stern, Naftali, Sofer, Yael, Sack, Jessica, Tirosh, Amir, Shehadeh, Naim, Darawsha, Mahmud, Skripova, Dasa, Pavleova, Eva, Kubincova, Ludmila, Merciakova, Martina, St-Amour, Eric, Yared, Zeina, Blouin, Francois, Aggarwal, Naresh K, Bajaj, Harpreet, Tailor, Chetna, Egan, Alan, St.Onge, Natasha, Borges, Joao L C, Franco, Denise R, Souza, Filipe D, Russo, Luis Augusto T, Sassone, Sonia A, Steinacher, Andrea, Perez Manghi, Federico C, Orio, Silvia I, Gelersztein, Elizabeth, Fretes, José O, Calella, Pedro R F, Zaidman, Cesar J, Chertkoff, Alejandro, Gonzalez Galvez, Guillermo, Calvo, Cesar G, Sowinski, Dariusz, Jozefowska, Malgorzata, Skokowska, Ewa, Modzelewska, Anna, Gilfillan, Christopher, Morbey, Claire, Kaur, Kamal, Kemp, Laurence, Shea, Antony J, Kunitsyna, Marina A, Ou, Horng-Yih, Chen, Jung-Fu, Hwu, Chii-Min, Doupis, John, Pagkalos, Emmanouil, Mouslech, Zadalla

Volltext

Licogliflozin for nonalcoholic steatohepatitis: a randomized, double-blind, placebo-controlled, phase 2a study von Harrison, Stephen A., Manghi, Federico Perez, Smith, William B., Alpenidze, Diana, Aizenberg, Diego, Klarenbeek, Naomi, Chen, Chi-Yi, Zuckerman, Eli, Ravussin, Eric, Charatcharoenwitthaya, Phunchai, Cheng, Pin-Nan, Katchman, Helena, Klein, Samuel, Ben-Ari, Ziv, Mendonza, Anisha E., Zhang, Yiming, Martic, Miljen, Ma, Shenglin, Kao, Sheena, Tanner, Sandra, Pachori, Alok, Badman, Michael K., He, YanLing, Ukomadu, Chinweike, Sicard, Eric

Volltext

Les diabétiques de type 2 traités par insuline degludec/liraglitude (IDegLira) ont plus de chances d’atteindre les objectifs glycémiques sans hypoglycémies ni prise de poids qu’ave... von Sérusclat, Pierre, Belhatem, Narimène, Lingvay, Ildiko, Norwood, Paul C., Begtrup, Kamilla, Langbakke, Irene H., Pérez Manghi, Federico C.

Volltext

CA-190 - Les diabétiques de type 2 traités par insuline degludec/liraglitude (IDegLira) ont plus de chances d’atteindre les objectifs glycémiques sans hypoglycémies ni prise de poi... von Sérusclat, Pierre, Belhatem, Narimène, Lingvay, Ildiko, Norwood, Paul C., Begtrup, Kamilla, Langbakke, Irene H., Pérez Manghi, Federico C.

Volltext

Efficacy and Safety of Dulaglutide in Hispanic/Latino Patients with Type 2 Diabetes in the Award Clinical Program von Davidson, Jaime A., Manghi, Federico Perez, Yu, Maria, Linetzky, Bruno, Landó, Laura Fernández

Volltext

140 - Patients with Type 2 Diabetes Treated with Insulin Degludec/Liraglutide Have a Greater Chance of Reaching Glycemic Targets Without Hypoglycemia and Weight Gain Than with Insu... von Lingvay, Ildiko, Norwood, Paul C., Begtrup, Kamilla, Langbakke, Irene H., Haynes, Marsha, Pèrez Manghi, Federico C.

Volltext

Patients with Type 2 Diabetes Treated with Insulin Degludec/Liraglutide Have a Greater Chance of Reaching Glycemic Targets Without Hypoglycemia and Weight Gain Than with Insulin Gl... von Lingvay, Ildiko, Norwood, Paul C., Begtrup, Kamilla, Langbakke, Irene H., Haynes, Marsha, Pèrez Manghi, Federico C.

Volltext